RemeGen Co., Ltd. (REGMF)
USD 1.5
(0.0%)
USD 1.5
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.09 Billion CNY | 100.88% |
| 2022 | 1.04 Billion CNY | 46.03% |
| 2021 | 712.78 Million CNY | 36.27% |
| 2020 | 523.07 Million CNY | -43.22% |
| 2019 | 921.28 Million CNY | -10.49% |
| 2018 | 1.02 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 418.33 Million USD | 28.74% |
| 2024 Q3 | 476.13 Million USD | 8.22% |
| 2024 Q1 | 332.02 Million USD | 14.78% |
| 2023 Q3 | 213.28 Million USD | -86.11% |
| 2023 Q1 | 145.14 Million USD | -86.06% |
| 2023 FY | 2.09 Billion CNY | 100.88% |
| 2023 Q4 | 288.25 Million USD | 35.15% |
| 2023 Q2 | 1.53 Billion CNY | 958.26% |
| 2022 Q3 | 99.18 Million USD | -85.03% |
| 2022 Q2 | 662.61 Million CNY | 521.18% |
| 2022 Q1 | 106.67 Million USD | -85.03% |
| 2022 FY | 1.04 Billion CNY | 46.03% |
| 2022 Q4 | 1.04 Billion CNY | 949.46% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 712.78 Million CNY | 36.27% |
| 2021 Q4 | 712.78 Million CNY | 0.0% |
| 2021 Q3 | - USD | -100.0% |
| 2021 Q2 | 555.01 Million CNY | 0.0% |
| 2020 FY | 523.07 Million CNY | -43.22% |
| 2020 Q4 | 523.07 Million CNY | 0.0% |
| 2020 Q2 | 829 Million CNY | 0.0% |
| 2019 FY | 921.28 Million CNY | -10.49% |
| 2019 Q4 | 921.28 Million CNY | 0.0% |
| 2018 FY | 1.02 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -3822.66% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -21721.845% |
| SQZ Biotechnologies Company | 50.03 Million USD | -4078.689% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -2785.256% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -3443.18% |
| Mesoblast Limited | 188.44 Million USD | -1009.596% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -54190.932% |
| Genus plc | 485 Million USD | -331.129% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -35688.287% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -82996.242% |
| Marizyme, Inc. | 26.67 Million USD | -7738.494% |
| ContraFect Corporation | 32.53 Million USD | -6327.635% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -54925.632% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -105435.03% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -54528.169% |
| Intellipharmaceutics International Inc. | 12 Million USD | -17312.062% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -17652.924% |
| MultiCell Technologies, Inc. | 1617.67 USD | -129258277.79% |
| Accustem Sciences Inc. | 1.07 Million USD | -193645.222% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -2600.924% |
| EV Biologics, Inc. | 2.11 Million USD | -98760.794% |
| Q BioMed Inc. | 8.13 Million USD | -25609.943% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -2421.22% |
| Neon Bloom, Inc. | 1.22 Million USD | -170422.903% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -40532.72% |
| Biomind Labs Inc. | 1.49 Million USD | -139427.376% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | -756.7% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -11261.88% |
| Skye Bioscience, Inc. | 14.07 Million USD | -14758.868% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -103921.829% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -1471432.425% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -21989.493% |
| IMV Inc. | 37.93 Million USD | -5412.312% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -1039585.555% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -36291.214% |
| GB Sciences, Inc. | 5.41 Million USD | -38496.253% |
| Alpha Cognition Inc. | 7.16 Million USD | -29084.089% |
| HST Global, Inc. | 593.59 Thousand USD | -352157.186% |
| CSL Limited | 18.62 Billion USD | 88.771% |
| Halberd Corporation | 728.71 Thousand USD | -286838.312% |
| Enzolytics Inc. | 365.26 Million USD | -472.448% |
| Resverlogix Corp. | 67.39 Million USD | -3002.519% |
| Affymax, Inc. | 8.87 Million USD | -23470.894% |
| SYBLEU INC | 681.41 Thousand USD | -306758.542% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -249201.803% |
| argenx SE | 444.95 Million USD | -369.934% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -2690.942% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -121893.816% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -17466.632% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -56949.944% |
| AVAX Technologies, Inc. | 3.99 Million USD | -52256.222% |
| Zenith Capital Corp. | 27.56 Thousand USD | -7584411.589% |
| Genscript Biotech Corporation | 1.32 Billion USD | -57.706% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -876052.924% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -55893.644% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -307019.503% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -1661.232% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -23024.631% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -3124067.401% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -145728.222% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -4059.983% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -77011.019% |
| BioStem Technologies, Inc. | 15.9 Million USD | -13046.921% |
| ONE Bio Corp. | 27.49 Million USD | -7504.7% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -449863.094% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -7622012.055% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -165956.673% |
| Agentix Corp. | 2.51 Million USD | -83187.321% |
| LadRx Corporation | 2.2 Million USD | -94921.468% |
| Cell Source, Inc. | 15.8 Million USD | -13128.391% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -4678112.815% |
| Regen BioPharma, Inc. | 5.45 Million USD | -38212.956% |
| Regen BioPharma, Inc. | 5.45 Million USD | -38212.956% |
| NovAccess Global Inc. | 7.86 Million USD | -26500.245% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -8349.736% |
| Itoco Inc. | 1.65 Million USD | -126384.151% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -101820.924% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -34467.267% |
| Kadimastem Ltd | 3.5 Million USD | -59559.154% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -495899.222% |
| CytoDyn Inc. | 127.89 Million USD | -1534.927% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -5002349.819% |
| Mobile Lads Corp. | 1.31 Million USD | -159091.38% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -133391.107% |
| Qrons Inc. | 1.48 Million USD | -140355.145% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -18830.913% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -258429.861% |
| Rebus Holdings, Inc. | 5.24 Million USD | -39788.859% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -34167.561% |
| International Stem Cell Corporation | 5.27 Million USD | -39524.294% |
| Bioxytran, Inc. | 3.24 Million USD | -64247.561% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -334023.351% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -45187.36% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -5000.434% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -9291.305% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -103138.245% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -38070.391% |
| Neutra Corp. | 973.52 Thousand USD | -214682.919% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -7106.528% |
| PureTech Health plc | 125.58 Million USD | -1565.014% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -55553.565% |
| IXICO plc | 1.9 Million USD | -109934.353% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -10085.464% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -1923.706% |
| CSL Limited | 18.62 Billion USD | 88.771% |
| Cellectis S.A. | 249.36 Million USD | -738.505% |